ReEndure’s IDRO Wearable Lactate Monitor Achieves 0.95 R² Accuracy, Nearing Commercial Launch for Athletes

September 20, 2026

ReEndure USA

Overview

ReEndure’s IDRO continuous lactate monitor has demonstrated high accuracy with an R² value of 0.95 when compared to ion chromatography, moving closer to commercial reality for endurance athletes. This wearable system utilizes a skin-worn cartridge, microfluidic sweat pathway, and electrochemical sensor to transmit real-time metabolic data to smartphones. Its ability to precisely measure sweat lactate from 1-50 mmol/L offers significant potential for optimizing athletic performance and holds promise for broader clinical applications, such as reducing sepsis risk.

In Depth

Key Findings

ReEndure’s IDRO continuous lactate monitor has achieved significant progress towards becoming a commercial product for endurance athletes, demonstrating high accuracy in real-time sweat lactate measurement. Further clinical research is now focused on its potential application in wearable continuous lactate sensors aimed at reducing sepsis risk, highlighting its broad applicability beyond sports performance.

Technical / Clinical Details

The IDRO system integrates a skin-worn cartridge with a microfluidic sweat pathway, an electrochemical sensor, and Bluetooth-connected electronics, enabling real-time metabolic data transmission to a smartphone. This innovative design allows for the continuous monitoring of sweat lactate within a range of approximately 1 to 50 mmol/L. Crucially, the system has reported an impressive R² value of 0.95 when compared to ion chromatography, a gold standard for lactate measurement, indicating a high degree of correlation and reliability. This high accuracy is a critical factor for both athletic performance optimization and potential medical applications, where precise lactate levels are vital indicators.

Background & Context

Lactate monitoring has traditionally relied on invasive blood sampling, which presents practical challenges for continuous, real-time assessment in dynamic environments like athletic training or critical care settings. The development of a highly accurate, non-invasive wearable solution like IDRO addresses a significant unmet need. For athletes, continuous lactate data can inform training intensity, prevent overtraining, and optimize recovery strategies. In the medical field, particularly in the context of sepsis, rising lactate levels are a critical early indicator of tissue hypoperfusion and organ dysfunction, making continuous monitoring a powerful tool for early detection and intervention.

Strategic Significance & Outlook

ReEndure aims to make the IDRO system commercially available in the sports market, leveraging its proven accuracy and user-friendly design. The successful validation against a benchmark method (ion chromatography) with such a high R² value positions IDRO as a strong contender in the wearable biosensor market. Beyond sports, the ongoing clinical research into sepsis risk reduction underscores the system’s potential to revolutionize patient monitoring in hospital settings. This technology represents a significant step towards more personalized and preventive healthcare, enabling individuals and clinicians to make timely, data-driven decisions based on physiological insights.

Source: https://www.reendure.com/post/continuous-lactate-monitors-endurance-athletes-2026

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.